nodes	percent_of_prediction	percent_of_DWPC	metapath
Clavulanate—Cystitis haemorrhagic—Epirubicin—pancreatic cancer	0.0369	0.0369	CcSEcCtD
Clavulanate—Cystitis haemorrhagic—Doxorubicin—pancreatic cancer	0.0341	0.0341	CcSEcCtD
Clavulanate—Swelling—Tamoxifen—pancreatic cancer	0.0185	0.0185	CcSEcCtD
Clavulanate—Hypokalaemia—Erlotinib—pancreatic cancer	0.0147	0.0147	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Erlotinib—pancreatic cancer	0.0146	0.0146	CcSEcCtD
Clavulanate—Thrombophlebitis—Irinotecan—pancreatic cancer	0.0133	0.0133	CcSEcCtD
Clavulanate—Thrombophlebitis—Fluorouracil—pancreatic cancer	0.0128	0.0128	CcSEcCtD
Clavulanate—Hypokalaemia—Sunitinib—pancreatic cancer	0.0127	0.0127	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Sunitinib—pancreatic cancer	0.0126	0.0126	CcSEcCtD
Clavulanate—Swelling—Fluorouracil—pancreatic cancer	0.0125	0.0125	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Tamoxifen—pancreatic cancer	0.0125	0.0125	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Erlotinib—pancreatic cancer	0.0124	0.0124	CcSEcCtD
Clavulanate—Haemoglobin—Tamoxifen—pancreatic cancer	0.0114	0.0114	CcSEcCtD
Clavulanate—Haemorrhage—Tamoxifen—pancreatic cancer	0.0113	0.0113	CcSEcCtD
Clavulanate—Hepatitis—Tamoxifen—pancreatic cancer	0.0113	0.0113	CcSEcCtD
Clavulanate—Haemoglobin—Erlotinib—pancreatic cancer	0.0112	0.0112	CcSEcCtD
Clavulanate—Haemorrhage—Erlotinib—pancreatic cancer	0.0112	0.0112	CcSEcCtD
Clavulanate—Hepatitis—Erlotinib—pancreatic cancer	0.0112	0.0112	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Sunitinib—pancreatic cancer	0.0107	0.0107	CcSEcCtD
Clavulanate—Erythema multiforme—Tamoxifen—pancreatic cancer	0.0107	0.0107	CcSEcCtD
Clavulanate—Erythema multiforme—Erlotinib—pancreatic cancer	0.0106	0.0106	CcSEcCtD
Clavulanate—Hypokalaemia—Irinotecan—pancreatic cancer	0.0105	0.0105	CcSEcCtD
Clavulanate—Hypokalaemia—Gemcitabine—pancreatic cancer	0.0102	0.0102	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Gemcitabine—pancreatic cancer	0.0101	0.0101	CcSEcCtD
Clavulanate—Haemoglobin—Sunitinib—pancreatic cancer	0.00973	0.00973	CcSEcCtD
Clavulanate—Haemorrhage—Sunitinib—pancreatic cancer	0.00968	0.00968	CcSEcCtD
Clavulanate—Hepatitis—Sunitinib—pancreatic cancer	0.00968	0.00968	CcSEcCtD
Clavulanate—Eosinophilia—Fluorouracil—pancreatic cancer	0.00945	0.00945	CcSEcCtD
Clavulanate—Thrombophlebitis—Docetaxel—pancreatic cancer	0.00921	0.00921	CcSEcCtD
Clavulanate—Erythema multiforme—Sunitinib—pancreatic cancer	0.00915	0.00915	CcSEcCtD
Clavulanate—Swelling—Docetaxel—pancreatic cancer	0.00903	0.00903	CcSEcCtD
Clavulanate—Leukopenia—Tamoxifen—pancreatic cancer	0.00881	0.00881	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Gemcitabine—pancreatic cancer	0.00858	0.00858	CcSEcCtD
Clavulanate—Jaundice cholestatic—Epirubicin—pancreatic cancer	0.00843	0.00843	CcSEcCtD
Clavulanate—Haemoglobin—Irinotecan—pancreatic cancer	0.00802	0.00802	CcSEcCtD
Clavulanate—Haemorrhage—Irinotecan—pancreatic cancer	0.00798	0.00798	CcSEcCtD
Clavulanate—Thrombocytopenia—Tamoxifen—pancreatic cancer	0.00786	0.00786	CcSEcCtD
Clavulanate—Haemoglobin—Gemcitabine—pancreatic cancer	0.00781	0.00781	CcSEcCtD
Clavulanate—Jaundice cholestatic—Doxorubicin—pancreatic cancer	0.0078	0.0078	CcSEcCtD
Clavulanate—Thrombocytopenia—Erlotinib—pancreatic cancer	0.00778	0.00778	CcSEcCtD
Clavulanate—Haemorrhage—Gemcitabine—pancreatic cancer	0.00777	0.00777	CcSEcCtD
Clavulanate—Haemoglobin—Fluorouracil—pancreatic cancer	0.00768	0.00768	CcSEcCtD
Clavulanate—Haemorrhage—Fluorouracil—pancreatic cancer	0.00764	0.00764	CcSEcCtD
Clavulanate—Leukopenia—Sunitinib—pancreatic cancer	0.00754	0.00754	CcSEcCtD
Clavulanate—Erythema multiforme—Gemcitabine—pancreatic cancer	0.00735	0.00735	CcSEcCtD
Clavulanate—Convulsion—Sunitinib—pancreatic cancer	0.0073	0.0073	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Docetaxel—pancreatic cancer	0.00718	0.00718	CcSEcCtD
Clavulanate—Pain—Tamoxifen—pancreatic cancer	0.00687	0.00687	CcSEcCtD
Clavulanate—Pain—Erlotinib—pancreatic cancer	0.0068	0.0068	CcSEcCtD
Clavulanate—Thrombocytopenia—Sunitinib—pancreatic cancer	0.00674	0.00674	CcSEcCtD
Clavulanate—Urticaria—Tamoxifen—pancreatic cancer	0.00638	0.00638	CcSEcCtD
Clavulanate—Leukopenia—Irinotecan—pancreatic cancer	0.00621	0.00621	CcSEcCtD
Clavulanate—Thrombophlebitis—Epirubicin—pancreatic cancer	0.00621	0.00621	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Docetaxel—pancreatic cancer	0.00609	0.00609	CcSEcCtD
Clavulanate—Leukopenia—Gemcitabine—pancreatic cancer	0.00605	0.00605	CcSEcCtD
Clavulanate—Leukopenia—Fluorouracil—pancreatic cancer	0.00595	0.00595	CcSEcCtD
Clavulanate—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00592	0.00592	CcSEcCtD
Clavulanate—Pain—Sunitinib—pancreatic cancer	0.00588	0.00588	CcSEcCtD
Clavulanate—Convulsion—Fluorouracil—pancreatic cancer	0.00576	0.00576	CcSEcCtD
Clavulanate—Thrombophlebitis—Doxorubicin—pancreatic cancer	0.00575	0.00575	CcSEcCtD
Clavulanate—Pruritus—Tamoxifen—pancreatic cancer	0.00568	0.00568	CcSEcCtD
Clavulanate—Anaphylactic shock—Irinotecan—pancreatic cancer	0.00567	0.00567	CcSEcCtD
Clavulanate—Pruritus—Erlotinib—pancreatic cancer	0.00562	0.00562	CcSEcCtD
Clavulanate—Thrombocytopenia—Irinotecan—pancreatic cancer	0.00555	0.00555	CcSEcCtD
Clavulanate—Haemoglobin—Docetaxel—pancreatic cancer	0.00554	0.00554	CcSEcCtD
Clavulanate—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.00552	0.00552	CcSEcCtD
Clavulanate—Haemorrhage—Docetaxel—pancreatic cancer	0.00551	0.00551	CcSEcCtD
Clavulanate—Hepatitis—Docetaxel—pancreatic cancer	0.00551	0.00551	CcSEcCtD
Clavulanate—Diarrhoea—Tamoxifen—pancreatic cancer	0.0055	0.0055	CcSEcCtD
Clavulanate—Diarrhoea—Erlotinib—pancreatic cancer	0.00544	0.00544	CcSEcCtD
Clavulanate—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.00543	0.00543	CcSEcCtD
Clavulanate—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.0054	0.0054	CcSEcCtD
Clavulanate—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.00531	0.00531	CcSEcCtD
Clavulanate—Erythema multiforme—Docetaxel—pancreatic cancer	0.00521	0.00521	CcSEcCtD
Clavulanate—Vomiting—Tamoxifen—pancreatic cancer	0.00511	0.00511	CcSEcCtD
Clavulanate—Hypersensitivity—Sunitinib—pancreatic cancer	0.00507	0.00507	CcSEcCtD
Clavulanate—Rash—Tamoxifen—pancreatic cancer	0.00506	0.00506	CcSEcCtD
Clavulanate—Dermatitis—Tamoxifen—pancreatic cancer	0.00506	0.00506	CcSEcCtD
Clavulanate—Vomiting—Erlotinib—pancreatic cancer	0.00505	0.00505	CcSEcCtD
Clavulanate—Rash—Erlotinib—pancreatic cancer	0.00501	0.00501	CcSEcCtD
Clavulanate—Dermatitis—Erlotinib—pancreatic cancer	0.00501	0.00501	CcSEcCtD
Clavulanate—Hypokalaemia—Epirubicin—pancreatic cancer	0.00489	0.00489	CcSEcCtD
Clavulanate—Pruritus—Sunitinib—pancreatic cancer	0.00487	0.00487	CcSEcCtD
Clavulanate—Pain—Irinotecan—pancreatic cancer	0.00485	0.00485	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.00484	0.00484	CcSEcCtD
Clavulanate—Nausea—Tamoxifen—pancreatic cancer	0.00477	0.00477	CcSEcCtD
Clavulanate—Pain—Gemcitabine—pancreatic cancer	0.00472	0.00472	CcSEcCtD
Clavulanate—Nausea—Erlotinib—pancreatic cancer	0.00472	0.00472	CcSEcCtD
Clavulanate—Diarrhoea—Sunitinib—pancreatic cancer	0.00471	0.00471	CcSEcCtD
Clavulanate—Pain—Fluorouracil—pancreatic cancer	0.00464	0.00464	CcSEcCtD
Clavulanate—Eosinophilia—Epirubicin—pancreatic cancer	0.0046	0.0046	CcSEcCtD
Clavulanate—Hypokalaemia—Doxorubicin—pancreatic cancer	0.00453	0.00453	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.00448	0.00448	CcSEcCtD
Clavulanate—Vomiting—Sunitinib—pancreatic cancer	0.00437	0.00437	CcSEcCtD
Clavulanate—Rash—Sunitinib—pancreatic cancer	0.00434	0.00434	CcSEcCtD
Clavulanate—Dermatitis—Sunitinib—pancreatic cancer	0.00433	0.00433	CcSEcCtD
Clavulanate—Urticaria—Fluorouracil—pancreatic cancer	0.00431	0.00431	CcSEcCtD
Clavulanate—Leukopenia—Docetaxel—pancreatic cancer	0.0043	0.0043	CcSEcCtD
Clavulanate—Eosinophilia—Doxorubicin—pancreatic cancer	0.00426	0.00426	CcSEcCtD
Clavulanate—Hypersensitivity—Irinotecan—pancreatic cancer	0.00417	0.00417	CcSEcCtD
Clavulanate—Convulsion—Docetaxel—pancreatic cancer	0.00416	0.00416	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.00411	0.00411	CcSEcCtD
Clavulanate—Nausea—Sunitinib—pancreatic cancer	0.00409	0.00409	CcSEcCtD
Clavulanate—Hypersensitivity—Fluorouracil—pancreatic cancer	0.004	0.004	CcSEcCtD
Clavulanate—Anaphylactic shock—Docetaxel—pancreatic cancer	0.00392	0.00392	CcSEcCtD
Clavulanate—Pruritus—Gemcitabine—pancreatic cancer	0.00391	0.00391	CcSEcCtD
Clavulanate—Diarrhoea—Irinotecan—pancreatic cancer	0.00388	0.00388	CcSEcCtD
Clavulanate—Pruritus—Fluorouracil—pancreatic cancer	0.00384	0.00384	CcSEcCtD
Clavulanate—Thrombocytopenia—Docetaxel—pancreatic cancer	0.00384	0.00384	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.0038	0.0038	CcSEcCtD
Clavulanate—Diarrhoea—Gemcitabine—pancreatic cancer	0.00378	0.00378	CcSEcCtD
Clavulanate—Haemoglobin—Epirubicin—pancreatic cancer	0.00374	0.00374	CcSEcCtD
Clavulanate—Haemorrhage—Epirubicin—pancreatic cancer	0.00372	0.00372	CcSEcCtD
Clavulanate—Hepatitis—Epirubicin—pancreatic cancer	0.00372	0.00372	CcSEcCtD
Clavulanate—Diarrhoea—Fluorouracil—pancreatic cancer	0.00371	0.00371	CcSEcCtD
Clavulanate—Vomiting—Irinotecan—pancreatic cancer	0.0036	0.0036	CcSEcCtD
Clavulanate—Rash—Irinotecan—pancreatic cancer	0.00357	0.00357	CcSEcCtD
Clavulanate—Dermatitis—Irinotecan—pancreatic cancer	0.00357	0.00357	CcSEcCtD
Clavulanate—Erythema multiforme—Epirubicin—pancreatic cancer	0.00352	0.00352	CcSEcCtD
Clavulanate—Vomiting—Gemcitabine—pancreatic cancer	0.00351	0.00351	CcSEcCtD
Clavulanate—Rash—Gemcitabine—pancreatic cancer	0.00348	0.00348	CcSEcCtD
Clavulanate—Dermatitis—Gemcitabine—pancreatic cancer	0.00348	0.00348	CcSEcCtD
Clavulanate—Haemoglobin—Doxorubicin—pancreatic cancer	0.00346	0.00346	CcSEcCtD
Clavulanate—Vomiting—Fluorouracil—pancreatic cancer	0.00345	0.00345	CcSEcCtD
Clavulanate—Haemorrhage—Doxorubicin—pancreatic cancer	0.00344	0.00344	CcSEcCtD
Clavulanate—Hepatitis—Doxorubicin—pancreatic cancer	0.00344	0.00344	CcSEcCtD
Clavulanate—Rash—Fluorouracil—pancreatic cancer	0.00342	0.00342	CcSEcCtD
Clavulanate—Dermatitis—Fluorouracil—pancreatic cancer	0.00342	0.00342	CcSEcCtD
Clavulanate—Nausea—Irinotecan—pancreatic cancer	0.00337	0.00337	CcSEcCtD
Clavulanate—Pain—Docetaxel—pancreatic cancer	0.00335	0.00335	CcSEcCtD
Clavulanate—Nausea—Gemcitabine—pancreatic cancer	0.00328	0.00328	CcSEcCtD
Clavulanate—Erythema multiforme—Doxorubicin—pancreatic cancer	0.00325	0.00325	CcSEcCtD
Clavulanate—Nausea—Fluorouracil—pancreatic cancer	0.00322	0.00322	CcSEcCtD
Clavulanate—Leukopenia—Epirubicin—pancreatic cancer	0.0029	0.0029	CcSEcCtD
Clavulanate—Hypersensitivity—Docetaxel—pancreatic cancer	0.00289	0.00289	CcSEcCtD
Clavulanate—Convulsion—Epirubicin—pancreatic cancer	0.0028	0.0028	CcSEcCtD
Clavulanate—Pruritus—Docetaxel—pancreatic cancer	0.00277	0.00277	CcSEcCtD
Clavulanate—Leukopenia—Doxorubicin—pancreatic cancer	0.00268	0.00268	CcSEcCtD
Clavulanate—Diarrhoea—Docetaxel—pancreatic cancer	0.00268	0.00268	CcSEcCtD
Clavulanate—Anaphylactic shock—Epirubicin—pancreatic cancer	0.00264	0.00264	CcSEcCtD
Clavulanate—Convulsion—Doxorubicin—pancreatic cancer	0.0026	0.0026	CcSEcCtD
Clavulanate—Thrombocytopenia—Epirubicin—pancreatic cancer	0.00259	0.00259	CcSEcCtD
Clavulanate—Vomiting—Docetaxel—pancreatic cancer	0.00249	0.00249	CcSEcCtD
Clavulanate—Rash—Docetaxel—pancreatic cancer	0.00247	0.00247	CcSEcCtD
Clavulanate—Dermatitis—Docetaxel—pancreatic cancer	0.00247	0.00247	CcSEcCtD
Clavulanate—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.00244	0.00244	CcSEcCtD
Clavulanate—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.00239	0.00239	CcSEcCtD
Clavulanate—Nausea—Docetaxel—pancreatic cancer	0.00233	0.00233	CcSEcCtD
Clavulanate—Pain—Epirubicin—pancreatic cancer	0.00226	0.00226	CcSEcCtD
Clavulanate—Urticaria—Epirubicin—pancreatic cancer	0.0021	0.0021	CcSEcCtD
Clavulanate—Pain—Doxorubicin—pancreatic cancer	0.00209	0.00209	CcSEcCtD
Clavulanate—Hypersensitivity—Epirubicin—pancreatic cancer	0.00195	0.00195	CcSEcCtD
Clavulanate—Urticaria—Doxorubicin—pancreatic cancer	0.00194	0.00194	CcSEcCtD
Clavulanate—Pruritus—Epirubicin—pancreatic cancer	0.00187	0.00187	CcSEcCtD
Clavulanate—Diarrhoea—Epirubicin—pancreatic cancer	0.00181	0.00181	CcSEcCtD
Clavulanate—Hypersensitivity—Doxorubicin—pancreatic cancer	0.0018	0.0018	CcSEcCtD
Clavulanate—Pruritus—Doxorubicin—pancreatic cancer	0.00173	0.00173	CcSEcCtD
Clavulanate—Vomiting—Epirubicin—pancreatic cancer	0.00168	0.00168	CcSEcCtD
Clavulanate—Diarrhoea—Doxorubicin—pancreatic cancer	0.00167	0.00167	CcSEcCtD
Clavulanate—Rash—Epirubicin—pancreatic cancer	0.00167	0.00167	CcSEcCtD
Clavulanate—Dermatitis—Epirubicin—pancreatic cancer	0.00166	0.00166	CcSEcCtD
Clavulanate—Nausea—Epirubicin—pancreatic cancer	0.00157	0.00157	CcSEcCtD
Clavulanate—Vomiting—Doxorubicin—pancreatic cancer	0.00155	0.00155	CcSEcCtD
Clavulanate—Rash—Doxorubicin—pancreatic cancer	0.00154	0.00154	CcSEcCtD
Clavulanate—Dermatitis—Doxorubicin—pancreatic cancer	0.00154	0.00154	CcSEcCtD
Clavulanate—Nausea—Doxorubicin—pancreatic cancer	0.00145	0.00145	CcSEcCtD
